The role of long non‑coding RNA H19 in breast cancer (Review)
- Authors:
- Ji Wang
- Jinyu Sun
- Fen Yang
-
Affiliations: The First Clinical Medical College of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, Jiangsu 211166, P.R. China - Published online on: November 14, 2019 https://doi.org/10.3892/ol.2019.11093
- Pages: 7-16
-
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
|
Kapranov P, Cheng J, Dike S, Nix DA, Duttagupta R, Willingham AT, Stadler PF, Hertel J, Hackermuller J, Hofacker IL, et al: RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science. 316:1484–1488. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Dahariya S, Paddibhatla I, Kumar S, Raghuwanshi S, Pallepati A and Gutti RK: Long non-coding RNA: Classification, biogenesis and functions in blood cells. Mol Immunol. 112:82–92. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Charles Richard JL and Eichhorn PJA: Platforms for investigating LncRNA functions. SLAS Technol. 23:493–506. 2018.PubMed/NCBI | |
|
Jia B, Xie T, Qiu X, Sun X, Chen J, Huang Z, Zheng X, Wang Z and Zhao J: Long noncoding RNA FALEC inhibits proliferation and metastasis of tongue squamous cell carcinoma by epigenetically silencing ECM1 through EZH2. Aging (Albany NY). 11:4990–5007. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Lim LJ, Wong S, Huang F, Lim S, Chong SS, Ooi LL, Kon OL and Lee CG: Roles and regulation of long non-coding RNAs in hepatocellular carcinoma. Cancer Res. 79:5131–5139. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Raveh E, Matouk IJ, Gilon M and Hochberg A: The H19 Long non-coding RNA in cancer initiation, progression and metastasis-a proposed unifying theory. Mol Cancer. 14:1842015. View Article : Google Scholar : PubMed/NCBI | |
|
Yoshimura H, Matsuda Y, Yamamoto M, Kamiya S and Ishiwata T: Expression and role of long non-coding RNA H19 in carcinogenesis. Front Biosci (Landmark Ed). 23:614–625. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Bao MH, Szeto V, Yang BB, Zhu SZ, Sun HS and Feng ZP: Long non-coding RNAs in ischemic stroke. Cell Death Dis. 9:2812018. View Article : Google Scholar : PubMed/NCBI | |
|
Zeng Y, Li TL, Zhang HB, Deng JL, Zhang R, Sun H, Wan ZR, Liu YZ, Zhu YS and Wang G: Polymorphisms in IGF2/H19 gene locus are associated with platinum-based chemotherapeutic response in Chinese patients with epithelial ovarian cancer. Pharmacogenomics. 20:179–188. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Ghaedi H, Zare A, Omrani MD, Doustimotlagh AH, Meshkani R, Alipoor S and Alipoor B: Genetic variants in long noncoding RNA H19 and MEG3 confer risk of type 2 diabetes in an Iranian population. Gene. 675:265–271. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Gomez J, Lorca R, Reguero JR, Martín M, Morís C, Alonso B, Iglesias S, Díaz-Molina B, Avanzas P and Coto E: Genetic variation at the long noncoding RNA H19 gene is associated with the risk of hypertrophic cardiomyopathy. Epigenomics. 10:865–873. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Tarnowski M, Tkacz M, Czerewaty M, Poniewierska-Baran A, Grymuła K and Ratajczak MZ: 5-Azacytidine inhibits human rhabdomyosarcoma cell growth by downregulating insulin-like growth factor 2 expression and reactivating the H19 gene product miR-675, which negatively affects insulin-like growth factors and insulin signaling. Int J Oncol. 46:2241–2250. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Wei Y, Liu Z and Fang J: H19 functions as a competing endogenous RNA to regulate human epidermal growth factor receptor expression by sequestering let7c in gastric cancer. Mol Med Rep. 17:2600–2606. 2018.PubMed/NCBI | |
|
Ma L, Tian X, Guo H, Zhang Z, Du C, Wang F, Xie X, Gao H, Zhuang Y, Kornmann M, et al: Long noncoding RNA H19 derived miR-675 regulates cell proliferation by down-regulating E2F-1 in human pancreatic ductal adenocarcinoma. J Cancer. 9:389–399. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang J, Han C, Ungerleider N, Chen W, Song K, Wang Y, Kwon H, Ma W and Wu T: A transforming growth factor-β and H19 signaling axis in tumor-initiating hepatocytes that regulates hepatic carcinogenesis. Hepatology. 69:1549–1563. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Han J, Han B, Wu X, Hao J, Dong X, Shen Q and Pang H: Knockdown of lncRNA H19 restores chemo-sensitivity in paclitaxel-resistant triple-negative breast cancer through triggering apoptosis and regulating Akt signaling pathway. Toxicol Appl Pharmacol. 359:55–61. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
El Hajj J, Nguyen E, Liu Q, Bouyer C, Adriaenssens E, Hilal G and Ségal-Bendirdjian E: Telomerase regulation by the long non-coding RNA H19 in human acute promyelocytic leukemia cells. Mol Cancer. 17:852018. View Article : Google Scholar : PubMed/NCBI | |
|
Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C and Thun MJ: Cancer statistics, 2006. CA Cancer J Clin. 56:106–130. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Lin Y, Fu F, Chen Y, Qiu W, Lin S, Yang P, Huang M and Wang C: Genetic variants in long noncoding RNA H19 contribute to the risk of breast cancer in a southeast China Han population. Onco Targets Ther. 10:4369–4378. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Cui P, Zhao Y, Chu X, He N, Zheng H, Han J, Song F and Chen K: SNP rs2071095 in LincRNA H19 is associated with breast cancer risk. Breast Cancer Res Treat. 171:161–171. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Lottin S, Adriaenssens E, Dupressoir T, Berteaux N, Montpellier C, Coll J, Dugimont T and Curgy JJ: Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells. Carcinogenesis. 23:1885–1895. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Berteaux N, Lottin S, Monte D, Pinte S, Quatannens B, Coll J, Hondermarck H, Curgy JJ, Dugimont T and Adriaenssens E: H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. J Biol Chem. 280:29625–29636. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou J, Yang L, Zhong T, Mueller M, Men Y, Zhang N, Xie J, Giang K, Chung H, Sun X, et al: H19 lncRNA alters DNA methylation genome wide by regulating S-adenosylhomocysteine hydrolase. Nat Commun. 6:102212015. View Article : Google Scholar : PubMed/NCBI | |
|
Vennin C, Spruyt N, Robin YM, Chassat T, Le Bourhis X and Adriaenssens E: The long non-coding RNA 91H increases aggressive phenotype of breast cancer cells and up-regulates H19/IGF2 expression through epigenetic modifications. Cancer Lett. 385:198–206. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Collette J, Le Bourhis X and Adriaenssens E: Regulation of human breast cancer by the long non-coding RNA H19. Int J Mol Sci. 18(pii): E23192017. View Article : Google Scholar : PubMed/NCBI | |
|
Keniry A, Oxley D, Monnier P, Kyba M, Dandolo L, Smits G and Reik W: The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r. Nat Cell Biol. 14:659–665. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zhai LL, Wang P, Zhou LY, Yin JY, Tang Q, Zhang TJ, Wang YX, Yang DQ, Lin J and Deng ZQ: Over-expression of miR-675 in formalin-fixed paraffin-embedded (FFPE) tissues of breast cancer patients. Int J Clin Exp Med. 8:11195–11201. 2015.PubMed/NCBI | |
|
Cordero F, Ferrero G, Polidoro S, Fiorito G, Campanella G, Sacerdote C, Mattiello A, Masala G, Agnoli C, Frasca G, et al: Differentially methylated microRNAs in prediagnostic samples of subjects who developed breast cancer in the European Prospective Investigation into Nutrition and Cancer (EPIC-Italy) cohort. Carcinogenesis. 36:1144–1153. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Vennin C, Spruyt N, Dahmani F, Julien S, Bertucci F, Finetti P, Chassat T, Bourette RP, Le Bourhis X and Adriaenssens E: H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b. Oncotarget. 6:29209–29223. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Matouk IJ, Raveh E, Abu-Lail R, Mezan S, Gilon M, Gershtain E, Birman T, Gallula J, Schneider T, Barkali M, et al: Oncofetal H19 RNA promotes tumor metastasis. Biochim Biophys Acta. 1843:1414–1426. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Wang J, Wang X, Chen T, Jiang L and Yang Q: Huaier extract inhibits breast cancer progression through a lncRNA-H19/miR-675-5p pathway. Cell Physiol Biochem. 44:581–593. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Tay Y, Rinn J and Pandolfi PP: The multilayered complexity of ceRNA crosstalk and competition. Nature. 505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Salmena L, Poliseno L, Tay Y, Kats L and Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Ebert MS and Sharp PA: Emerging roles for natural microRNA sponges. Curr Biol. 20:R858–R861. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Franco-Zorrilla JM, Valli A, Todesco M, Mateos I, Puga MI, Rubio-Somoza I, Leyva A, Weigel D, Garcia JA and Paz-Ares J: Target mimicry provides a new mechanism for regulation of microRNA activity. Nat Genet. 39:1033–1037. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou W, Ye XL, Xu J, Cao MG, Fang ZY, Li LY, Guan GH, Liu Q, Qian YH and Xie D: The lncRNA H19 mediates breast cancer cell plasticity during EMT and MET plasticity by differentially sponging miR-200b/c and let-7b. Sci Signal. 10(pii): eaak95572017. View Article : Google Scholar : PubMed/NCBI | |
|
Li Z, Li Y, Li Y, Ren K, Li X, Han X and Wang J: Long non-coding RNA H19 promotes the proliferation and invasion of breast cancer through upregulating DNMT1 expression by sponging miR-152. J Biochem Mol Toxicol. 312017.doi: 10.1002/jbt.21933. | |
|
Li JP, Xiang Y, Fan LJ, Yao A, Li H and Liao XH: Long noncoding RNA H19 competitively binds miR-93-5p to regulate STAT3 expression in breast cancer. J Cell Biochem. 120:3137–3148. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Peng F, Li TT, Wang KL, Xiao GQ, Wang JH, Zhao HD, Kang ZJ, Fan WJ, Zhu LL, Li M, et al: H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance. Cell Death Dis. 8:e25692017. View Article : Google Scholar : PubMed/NCBI | |
|
Peng F, Wang JH, Fan WJ, Meng YT, Li MM, Li TT, Cui B, Wang HF, Zhao Y, An F, et al: Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia. Oncogene. 37:1062–1074. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Liang R, Li Y, Wang M, Tang SC, Xiao G, Sun X, Li G, Du N, Liu D and Ren H: MiR-146a promotes the asymmetric division and inhibits the self-renewal ability of breast cancer stem-like cells via indirect upregulation of Let-7. Cell Cycle. 17:1445–1456. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Wang M, Li Y, Xiao GD, Zheng XQ, Wang JC, Xu CW, Qin S, Ren H, Tang SC and Sun X: H19 regulation of oestrogen induction of symmetric division is achieved by antagonizing Let-7c in breast cancer stem-like cells. Cell Prolif. 52:e125342019. View Article : Google Scholar : PubMed/NCBI | |
|
De Martino M, Forzati F, Marfella M, Pellecchia S, Arra C, Terracciano L, Fusco A and Esposito F: HMGA1P7-pseudogene regulates H19 and Igf2 expression by a competitive endogenous RNA mechanism. Sci Rep. 6:376222016. View Article : Google Scholar : PubMed/NCBI | |
|
Liu L, Liu L and Lu S: lncRNA H19 promotes viability and epithelial-mesenchymal transition of lung adenocarcinoma cells by targeting miR-29b-3p and modifying STAT3. Int J Oncol. 54:929–941. 2019.PubMed/NCBI | |
|
Pan Y, Zhang Y, Liu W, Huang Y, Shen X, Jing R, Pu J, Wang X, Ju S, Cong H and Chen H: LncRNA H19 overexpression induces bortezomib resistance in multiple myeloma by targeting MCL-1 via miR-29b-3p. Cell Death Dis. 10:1062019. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng X, Zhou Y, Chen W, Chen L, Lu J, He F, Li X and Zhao L: Ginsenoside 20(S)-Rg3 prevents PKM2-targeting miR-324-5p from H19 sponging to antagonize the warburg effect in ovarian cancer cells. Cell Physiol Biochem. 51:1340–1353. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Sun Y, Zhu Q, Yang W, Shan Y, Yu Z, Zhang Q and Wu H: LncRNA H19/miR-194/PFTK1 axis modulates the cell proliferation and migration of pancreatic cancer. J Cell Biochem. 120:3874–3886. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Wei J, Gan Y, Peng D, Jiang X, Kitazawa R, Xiang Y, Dai Y, Tang Y and Yang J: Long non-coding RNA H19 promotes TDRG1 expression and cisplatin resistance by sequestering miRNA-106b-5p in seminoma. Cancer Med. 7:6247–6257. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Li M, Chai HF, Peng F, Meng YT, Zhang LZ, Zhang L, Zou H, Liang QL, Li MM, Mao KG, et al: Estrogen receptor β upregulated by lncRNA-H19 to promote cancer stem-like properties in papillary thyroid carcinoma. Cell Death Dis. 9:11202018. View Article : Google Scholar : PubMed/NCBI | |
|
Wei LQ, Li L, Lu C, Liu J, Chen Y and Wu H: Involvement of H19/miR-326 axis in hepatocellular carcinoma development through modulating TWIST1. J Cell Physiol. 234:5153–5162. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Li CF, Li YC, Wang Y and Sun LB: The Effect of LncRNA H19/miR-194-5p axis on the Epithelial-mesenchymal transition of colorectal adenocarcinoma. Cell Physiol Biochem. 50:196–213. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Yan L, Zhou J, Gao Y, Ghazal S, Lu L, Bellone S, Yang Y, Liu N, Zhao X, Santin AD, et al: Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation. Oncogene. 34:3076–3084. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Barsyte-Lovejoy D, Lau SK, Boutros PC, Khosravi F, Jurisica I, Andrulis IL, Tsao MS and Penn LZ: The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res. 66:5330–5337. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Tessier CR, Doyle GA, Clark BA, Pitot HC and Ross J: Mammary tumor induction in transgenic mice expressing an RNA-binding protein. Cancer Res. 64:209–214. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Q, Yang B, Xie X, Wei L, Liu W, Yang W, Ge Y, Zhu Q, Zhang J, Jiang L, et al: Vigilin interacts with CCCTC-binding factor (CTCF) and is involved in CTCF-dependent regulation of the imprinted genes Igf2 and H19. FEBS J. 281:2713–2725. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Stedman W, Kang H, Lin S, Kissil JL, Bartolomei MS and Lieberman PM: Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators. EMBO J. 27:654–666. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Popkie AP, Zeidner LC, Albrecht AM, D'Ippolito A, Eckardt S, Newsom DE, Groden J, Doble BW, Aronow B, McLaughlin KJ, et al: Phosphatidylinositol 3-kinase (PI3K) signaling via glycogen synthase kinase-3 (Gsk-3) regulates DNA methylation of imprinted loci. J Biol Chem. 285:41337–41347. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang K, Luo Z, Zhang Y, Zhang L, Wu L, Liu L, Yang J, Song X and Liu J: Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer. Cancer Biomark. 17:187–194. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Jiao ZY, Tian Q, Li N, Wang HB and Li KZ: Plasma long non-coding RNAs (lncRNAs) serve as potential biomarkers for predicting breast cancer. Eur Rev Med Pharmacol Sci. 22:1994–1999. 2018.PubMed/NCBI | |
|
Zhang Z, Weaver DL, Olsen D, DeKay J, Peng Z, Ashikaga T and Evans MF: Long non-coding RNA chromogenic in situ hybridisation signal pattern correlation with breast tumour pathology. J Clin Pathol. 69:76–81. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Shima H, Kida K, Adachi S, Yamada A, Sugae S, Narui K, Miyagi Y, Nishi M, Ryo A, Murata S, et al: Lnc RNA H19 is associated with poor prognosis in breast cancer patients and promotes cancer stemness. Breast Cancer Res Treat. 170:507–516. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Riaz M, Berns EM, Sieuwerts AM, Ruigrok-Ritstier K, de Weerd V, Groenewoud A, Uitterlinden AG, Look MP, Klijn JG, Sleijfer S, et al: Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes. Breast Cancer Res Treat. 133:843–851. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Han L, Ma P, Liu SM and Zhou X: Circulating long noncoding RNA GAS5 as a potential biomarker in breast cancer for assessing the surgical effects. Tumour Biol. 37:6847–6854. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Si X, Zang R, Zhang E, Liu Y, Shi X, Zhang E, Shao L, Li A, Yang N, Han X, et al: LncRNA H19 confers chemoresistance in ERα-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK. Oncotarget. 7:81452–81462. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Basak P, Chatterjee S, Weger S, Bruce MC, Murphy LC and Raouf A: Estrogen regulates luminal progenitor cell differentiation through H19 gene expression. Endocr Relat Cancer. 22:505–517. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Basak P, Chatterjee S, Bhat V, Su A, Jin H, Lee-Wing V, Liu Q, Hu P, Murphy LC and Raouf A: Long non-coding RNA H19 acts as an estrogen receptor modulator that is required for endocrine therapy resistance in ER+ breast cancer cells. Cell Physiol Biochem. 51:1518–1532. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu QN, Wang G, Guo Y, Peng Y, Zhang R, Deng JL, Li ZX and Zhu YS: LncRNA H19 is a major mediator of doxorubicin chemoresistance in breast cancer cells through a cullin4A-MDR1 pathway. Oncotarget. 8:91990–92003. 2017.PubMed/NCBI | |
|
Abdel Hadi M: Breast cancer in developing countries: The shrinking age gap. Breast J. 25:795–797. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Sinaga ES, Ahmad RA, Shivalli S and Hutajulu SH: Age at diagnosis predicted survival outcome of female patients with breast cancer at a tertiary hospital in Yogyakarta, Indonesia. Pan Afr Med J. 31:1632018. View Article : Google Scholar : PubMed/NCBI | |
|
Fazel A, Hasanpour-Heidari S, Salamat F, Rajaie S, Kazeminezhad V, Naeimi-Tabiei M, Jahangirrad A, Sedaghat S, Hosseinpoor R, Ghasemi-Kebria F, et al: Marked increase in breast cancer incidence in young women: A 10-year study from Northern Iran, 2004–2013. Cancer Epidemiol. 62:1015732019. View Article : Google Scholar : PubMed/NCBI | |
|
Kaminska M, Ciszewski T, Łopacka-Szatan K, Miotla P and Staroslawska E: Breast cancer risk factors. Prz Menopauzalny. 14:196–202. 2015.PubMed/NCBI | |
|
Tan BS, Yang MC, Singh S, Chou YC, Chen HY, Wang MY, Wang YC and Chen RH: LncRNA NORAD is repressed by the YAP pathway and suppresses lung and breast cancer metastasis by sequestering S100P. Oncogene. 38:5612–5626. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Cairns J, Ingle JN, Kalari KR, Shepherd LE, Kubo M, Goetz MP, Weinshilboum RM and Wang L: The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1. Breast Cancer Res. 21:472019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang H, Zhang N, Liu Y, Su P, Liang Y, Li Y, Wang X, Chen T, Song X, Sang Y, et al: Epigenetic regulation of NAMPT by NAMPT-AS drives metastatic progression in triple-negative breast cancer. Cancer Res. 79:3347–3359. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Chen F, Chen J, Yang L, Liu J, Zhang X, Zhang Y, Tu Q, Yin D, Lin D, Wong PP, et al: Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells. Nat Cell Biol. 21:498–510. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Jin X, Xu XE, Jiang YZ, Liu YR, Sun W, Guo YJ, Ren YX, Zuo WJ, Hu X, Huang SL, et al: The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation. Sci Adv. 5:eaat98202019. View Article : Google Scholar : PubMed/NCBI | |
|
Dong H, Hu J, Zou K, Ye M, Chen Y, Wu C, Chen X and Han M: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer. Mol Cancer. 18:32019. View Article : Google Scholar : PubMed/NCBI | |
|
Lu G, Li Y, Ma Y, Lu J, Chen Y, Jiang Q, Qin Q, Zhao L, Huang Q, Luo Z, et al: Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis. J Exp Clin Cancer Res. 37:2892018. View Article : Google Scholar : PubMed/NCBI | |
|
Yu G, Zhang W, Zhu L and Xia L: Upregulated long non-coding RNAs demonstrate promising efficacy for breast cancer detection: A meta-analysis. Onco Targets Ther. 11:1491–1499. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Ren J, Fu J, Ma T, Yan B, Gao R, An Z and Wang D: LncRNA H19-elevated LIN28B promotes lung cancer progression through sequestering miR-196b. Cell Cycle. 17:1372–1380. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Huang Z, Lei W, Hu HB, Zhang H and Zhu Y: H19 promotes non-small-cell lung cancer (NSCLC) development through STAT3 signaling via sponging miR-17. J Cell Physiol. 233:6768–6776. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Q, Li X, Li X, Li X and Chen Z: LncRNA H19 promotes epithelial-mesenchymal transition (EMT) by targeting miR-484 in human lung cancer cells. J Cell Biochem. 119:4447–4457. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Q, Cheng N, Li X, Pan H, Li C, Ren S, Su C, Cai W, Zhao C, Zhang L and Zhou C: Correlation of long non-coding RNA H19 expression with cisplatin-resistance and clinical outcome in lung adenocarcinoma. Oncotarget. 8:2558–2567. 2017.PubMed/NCBI | |
|
Yan J, Zhang Y, She Q, Li X, Peng L, Wang X, Liu S, Shen X, Zhang W, Dong Y, et al: Long noncoding RNA H19/miR-675 axis promotes gastric cancer via FADD/caspase 8/caspase 3 signaling pathway. Cell Physiol Biochem. 42:2364–2376. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Ishii S, Yamashita K, Harada H, Ushiku H, Tanaka T, Nishizawa N, Yokoi K, Washio M, Ema A, Mieno H, et al: The H19-PEG10/IGF2BP3 axis promotes gastric cancer progression in patients with high lymph node ratios. Oncotarget. 8:74567–74581. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Ma C, Nong K, Zhu H, Wang W, Huang X, Yuan Z and Ai K: H19 promotes pancreatic cancer metastasis by derepressing let-7's suppression on its target HMGA2-mediated EMT. Tumour Biol. 35:9163–9169. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Ma H, Yuan L, Li W, Xu K and Yang L: The LncRNA H19/miR-193a-3p axis modifies the radio-resistance and chemotherapeutic tolerance of hepatocellular carcinoma cells by targeting PSEN1. J Cell Biochem. 119:8325–8335. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Pope C, Mishra S, Russell J, Zhou Q and Zhong XB: Targeting H19, an imprinted long non-coding RNA, in hepatic functions and liver diseases. Diseases. 5:E112017. View Article : Google Scholar : PubMed/NCBI | |
|
Yang W, Redpath RE, Zhang C and Ning N: Long non-coding RNA H19 promotes the migration and invasion of colon cancer cells via MAPK signaling pathway. Oncol Lett. 16:3365–3372. 2018.PubMed/NCBI | |
|
Yang W, Ning N and Jin X: The lncRNA H19 promotes cell proliferation by competitively binding to miR-200a and derepressing β-catenin expression in colorectal cancer. Biomed Res Int. 2017:27674842017.PubMed/NCBI | |
|
Yang Q, Wang X, Tang C, Chen X and He J: H19 promotes the migration and invasion of colon cancer by sponging miR-138 to upregulate the expression of HMGA1. Int J Oncol. 50:1801–1809. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Chen SW, Zhu J, Ma J, Zhang JL, Zuo S, Chen GW, Wang X, Pan YS, Liu YC and Wang PY: Overexpression of long non-coding RNA H19 is associated with unfavorable prognosis in patients with colorectal cancer and increased proliferation and migration in colon cancer cells. Oncol Lett. 14:2446–2452. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang L, Wang DL and Yu P: LncRNA H19 regulates the expression of its target gene HOXA10 in endometrial carcinoma through competing with miR-612. Eur Rev Med Pharmacol Sci. 22:4820–4827. 2018.PubMed/NCBI | |
|
Zhao L, Li Z, Chen W, Zhai W, Pan J, Pang H and Li X: H19 promotes endometrial cancer progression by modulating epithelial-mesenchymal transition. Oncol Lett. 13:363–369. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Ghazal S, McKinnon B, Zhou J, Mueller M, Men Y, Yang L, Mueller M, Flannery C, Huang Y and Taylor HS: H19 lncRNA alters stromal cell growth via IGF signaling in the endometrium of women with endometriosis. EMBO Mol Med. 7:996–1003. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu Z, Xu L, Wan Y, Zhou J, Fu D, Chao H, Bao K and Zeng T: Inhibition of E-cadherin expression by lnc-RNA H19 to facilitate bladder cancer metastasis. Cancer Biomark. 22:275–281. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Lv M, Zhong Z, Huang M, Tian Q, Jiang R and Chen J: lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA. Biochim Biophys Acta Mol Cell Res. 1864:1887–1899. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Liu C, Chen Z, Fang J, Xu A, Zhang W and Wang Z: H19-derived miR-675 contributes to bladder cancer cell proliferation by regulating p53 activation. Tumour Biol. 37:263–270. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Luo M, Li Z, Wang W, Zeng Y, Liu Z and Qiu J: Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression. FEBS J. 280:1709–1716. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Ramnarine VR, Alshalalfa M, Mo F, Nabavi N, Erho N, Takhar M, Shukin R, Brahmbhatt S, Gawronski A, Kobelev M, et al: The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications. Gigascience. Jun 1–2018.(Epub ahead of print). doi: 10.1093/gigascience/giy050. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu M, Chen Q, Liu X, Sun Q, Zhao X, Deng R, Wang Y, Huang J, Xu M, Yan J and Yu J: lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI. FEBS J. 281:3766–3775. 2014. View Article : Google Scholar : PubMed/NCBI |
